Prolonged antibiotic therapy is associated with antimicrobial resistance and increased mortality in preterm infants. We evaluated the impact of an automatic stop order (ASO) and C-reactive protein (CRP) on the duration of antibiotics and level of intervention in infants screened for early-onset sepsis who had negative cultures. We introduced an ASO for low-risk infants, then, consequently, for all infants treated for suspected sepsis. We subsequently introduced a single CRP measurement at 36 hours. Between 2011 and 2014, 4 time periods were studied, at baseline and after each intervention. The proportion of infants receiving ≤48 hours of antibiotics increased from 19% to 72.5% (P < .0001), whereas that of infants receiving avoidable doses (>48 hours and <5 days) fell from 50% to 0.8% (P < .0001). The use of an ASO decreased the proportion receiving avoidable doses from 26/92 (28.3%) to 9/293 (3.1%); P < .0001. There was a reduction in lumbar punctures performed, from 35% to 20%; P = .015.
Introduction
Early-onset sepsis (EOS) within 72 hours of birth is a significant cause of morbidity and mortality in the newborn period. However, the incidence of culture-proven sepsis in clinically suspected cases is low, ranging from 2.7% to 5.6%. 1 The positive-predictive value of tests for neonatal infection is low, and as a result, clinicians often treat well infants for prolonged periods of time, even in the context of negative cultures. Inappropriate use of antibiotic therapy is associated with antimicrobial resistance; increased workload, hospital stay, and parental anxiety; and in preterm infants, an increased risk of necrotizing enterocolitis, late-onset sepsis, and increased mortality. 2, 3 Recent UK and US professional guidance on the assessment and management of EOS accepts the need to balance the imperative for prompt treatment with the risk of prolonged exposure to antimicrobial therapy. 4, 5 However, reports evaluating the implementation of such guidance into clinical practice have shown an increased level of intervention and longer duration of antibiotic treatment. 6, 7 The use of automatic stop orders (ASOs) in conjunction with a multidisciplinary intervention to reduce inappropriate prescribing has been shown to lead to a reduction in both antibiotic duration and adverse effects in the adult population. 8 There are no studies that assess the impact of ASOs in pediatric or neonatal patients.
In our tertiary neonatal intensive care unit, the rate of culture-positive EOS is approximately 0.5/1000 live births. Despite the low rate of positivity, more than 80% of infants in our unit investigated for EOS received antibiotics for greater than 48 hours.
Within a retrospective observational study, we evaluated the impact of 2 quality improvement initiatives: an ASO and a single C-reactive protein (CRP) measurement, on the duration of antibiotic treatment and level of
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Methods

Setting
The Simpson Neonatal Unit of the Royal Infirmary of Edinburgh has 39 cots and is a tertiary center for babies requiring intensive care in the South East of Scotland. The regional birth rate is approximately 15 000 per annum, with the neonatal unit admitting approximately 1000 infants, of whom 100 to 130 are inborn and very low birth weight. The neonatal unit has a clinical staff complement of around 150 people comprising senior and junior doctors, nurses, and allied health professionals.
Context
All infants suspected of EOS are assessed clinically on admission and have blood cultures taken before commencing antibiotics. Blood cultures are taken using an aseptic closed circuit technique from a peripheral vein, aiming for 1 mL per sample. Admission antibiotics are prescribed in preterm infants using a risk-based approach with or without the presence of clinical signs and in term infants, only where clinical signs of infection are evident, in the presence or absence of preceding risk factors. Lumbar punctures (LPs) are performed on the basis of clinical risk assessment and/or the subsequent presence of a pathogen in blood cultures and not according to a CRP threshold.
Data Collection
We evaluated retrospectively the records of all inborn infants identified from our hospital database who were screened for EOS but who had negative cultures, in 4 separate but consecutive time periods between 2011 and 2014. Epochs were of different durations because of availability of study personnel, but each period aimed to study 100 to 150 infants. Data were collected relating to compliance with the intervention and duration of antibiotics.
Each time period utilized cumulative decisionfacilitating tools (Table 1) . At baseline, in period 1, clinical assessment (including the consideration of risk factors for EOS), routine hematology, and blood culture results informed antibiotic duration.
At the beginning of period 2, ASOs were introduced and were applied at clinician discretion on initial prescriptions of antibiotics where the risk of EOS was not deemed to be high. This order limited administration to 48 hours while awaiting culture results. If a decision was made to continue antibiotics, these were then represcribed. This approach was continued through study period 3, with increasing compliance, and became a mandatory requirement at initial prescription prior to study period 4.
At the beginning of period 3, a single CRP measurement was introduced, taken 36 hours after commencement of antibiotics. The timing was selected on the best evidence available by our local guideline group and predated publication of national guidance. A level of ≤10 mg/dL was interpreted as carrying a low risk of congenital infection. Antibiotics were discontinued if both clinical suspicion and CRP were low, and blood cultures were negative. CRP level alone did not inform the need for LP. The use of a single CRP measurement continued through period 4.
Before study period 4, an ASO was made mandatory for all antibiotic prescriptions, regardless of clinical likelihood of infection. This move was undertaken because it had been observed over preceding study periods that the decision to apply an ASO was most often made by relatively junior clinicians at the bedside who were less confident about taking responsibility for curtailing antibiotic use. This mandatory stop order again applied on initial prescription and limited administration to 48 hours while awaiting blood culture results. If a decision was made to continue antibiotics, these were then represcribed.
Within our clinical practice, an empirical course was defined as 48 hours of antibiotics or less because culture results were available within 48 hours from sampling. A treatment course was defined as 5 days or more of antibiotic treatment. In our institution, shorter courses of treatment for suspected or proven infection are not administered. Avoidable dosing was defined as any course lasting longer than 48 hours but shorter than 5 days. Such dosing was usually a result of uncertainty or a delay in decision making and not informed by serial CRP measurement, a practice not undertaken in our service. We evaluated gestational age, antibiotic duration, CRP level, use of an ASO, and LP procedures and reviewed the clinical course. Exclusion criteria included culture-positive sepsis, out-born status, transfer to another hospital before completion of antibiotic course, or death within 5 days of admission. The χ 2 and Fisher exact tests were used to compare proportions of infants in separate study periods. Table 2 describes the number of infants and the interventions introduced to aid decisions about antibiotic duration throughout the study periods. Compliance increased for ASO through periods 2 to 4, but compliance for CRP measurement was high throughout both periods 3 and 4 (see Table 1 ). In each time period, the median gestation of infants was 37 weeks and ranged from 24 to 42 weeks. The incidence of culture-positive EOS during each of the study periods ranged from 0.3 to 1 per 1000 live births, and these infants, all of whom received full treatment, were excluded from analysis. Table 3 and Figure 1 describe the pattern of antibiotic administration during the 4 periods according to use of ASO and CRP. The proportion of infants receiving an empirical course increased from 18.8% to 72.5%; P < .0001. The proportion of infants who received neither an empirical course nor a treatment course (ie, avoidable dosing) fell from 50.4% to 0.8%; P < .0001. In no time period was any infant readmitted or reassessed for partially treated infection or late growth of bacteria on culture. In comparing the cohort of infants before and after the introduction of a single CRP measurement, there was no significant difference in the proportion of infants receiving a treatment course (29.1% vs 22.2%).
Results
The Effect of ASO and CRP on Empirical and Treatment Courses
Effectiveness of ASO Use on Avoidable Dosing
During periods 2 through 4, there was variable compliance for ASO use (60%-97.5%; see Table 2 ). The effect of ASO use on avoidable dosing was evaluated. In the group of infants where an ASO was used during the 3 study periods, the number receiving avoidable doses of antibiotics was 9/293 (3.1%) compared with 26/92 (28.3%) infants where an ASO was not used; P < .0001.
Effect of CRP on Lumbar Puncture
The number of LPs performed was available for periods 1 and 4, and there was a reduction from 35/101 (35%) to 24/120 (20%) over time; P = .015. No infant with negative blood cultures was diagnosed or treated for meningitis. 
Discussion
In this retrospective study, which evaluated decisionmaking tools in newborn infants screened for EOS but with negative cultures, we found that the use of an ASO and single CRP measurement led to an increase in the number of infants receiving antibiotics for 48 hours or less and a decrease in the number of infants receiving avoidable doses. The introduction of a single CRP measurement was associated with a trend to a reduction in the number of treatment courses of 5 days or more but did not increase the number of LPs performed. This is the first study evaluating the use of an ASO in a neonatal or pediatric population. In adults, ASOs have been shown to reduce both the duration and cost of antibiotic therapy and antibiotic-related adverse effects, 8, 9 and as such, their implementation is recommended both by the UK Department of Health and the Centers for Disease Prevention and Control as an essential component of antimicrobial stewardship. 10, 11 We suggest that not only will this simple and effective measure reduce drug cost and toxicity, but it will also have a positive impact on workload, length of stay, and parental experience. Furthermore, reducing antibiotic exposure very early in life may lead to longer-term health benefits related to the establishment of normal intestinal flora in addition to modification of risk for chronic diseases such as asthma, obesity, and inflammatory bowel disease. 12, 13 In our institution, 2 clear antimicrobial prescribing strategies are used: an empirical course for those infants with initial clinical symptoms or risk factors but who do not subsequently have evidence of infection and a treatment course for those with proven or ongoing suspicion of infection. It is well recognized in our institution and others, that because of uncertainty, delay, or inexperience in decision making, many infants receive neither an empirical nor a treatment course and, therefore, receive unnecessary extra doses of antibiotics. Our data show that high compliance with an ASO in our unit reduces this occurrence to less than 1%.
Collaboration with laboratory staff to ensure realtime reporting of positive cultures and reducing time to sample incubation means that relevant data are available at 48 hours along with a CRP result to facilitate the decision about antibiotic duration. This decision, which included consideration of clinical status, became a senior responsibility in our service, which may have facilitated the trend to less treatment courses overall. With UK guidance from the National Institute of Clinical Excellence advising that the use of a CRP measurement 18 to 24 hours following antibiotic initiation is the most useful biochemical marker to aid the decision to continue antibiotics 4 and with the recommendation that hospitals should have systems in place to make blood culture results available to health care professionals within 36 hours of presentation, it is likely that earlier decision making will facilitate earlier discharge of babies, reduce health care costs, improve capacity within neonatal services, and reduce long-term adverse effects from the use of early antimicrobial treatment.
National Institute for Health and Care Excellence guidance, which aims to provide a consistent approach to the investigation and treatment of EOS, suggests giving "consideration" to performing a LP based on a CRP level of 10 or greater, positive blood culture results, or poor response to antimicrobial therapy. 4 Guidance from the Committee of the Fetus and Newborn (COFN) states that a LP "should be performed" in any infant with a positive blood culture, infants whose clinical course or laboratory data (Full Blood Count ± CRP) strongly suggest bacterial sepsis, and infants who initially worsen with antimicrobial therapy. 5 Recent studies of the local interpretation of such guidance in clinical practice have shown an association with increased frequency of LP both in the United Kingdom and the United States, most likely related to the local implementation of an operational threshold for laboratory markers such as CRP in informing need for LP. 6, 7 Our study did not identify an increase in LP following implementation of a single CRP measurement. We instead observed a reduction in the number of procedures undertaken and propose that this was a result of a nonreliance on CRP alone as the justification for LP, in addition to the greater reassurance provided by a low CRP measurement. Recent studies also describe a longer length of stay following implementation of guidance. 6, 7 Although our study did not examine this formally, well term infants were generally approved for discharge from hospital on the day antibiotics were stopped, and a reduced length of stay could be inferred from our data.
Our initiative included both term and preterm infants but did not seek to examine differences in antibiotic exposure between gestational groups. Overreliance on the validity of CRP measurements may be of more concern in the preterm infant whose inflammatory response may be impaired while being at greater risk of EOS than term infants.
14 In such infants, blood cultures may also be negative in the context of low-colony-count sepsis and maternal antibiotics. Nevertheless, the negative impact of prolonged antibiotics is better described in immature infants with specific associations of death and necrotizing enterocolitis. 2, 3 As preterm infants continue to be observed in hospital after antibiotics are discontinued, it would be important to determine the health benefits of minimizing antibiotic exposure in this population, both in suspected EOS and late-onset infection.
Because of its periodic and retrospective design, our study was limited by case ascertainment; but even if all missing infants were assigned to a favorable antibiotic duration category (≤48 hours), our findings would remain significant. We excluded infants with culturepositive sepsis, relying on blood culture results alone to diagnose EOS, but blood cultures may be unreliable in the context of maternal antibiotics and are reliant on the technical skill of the operator obtaining the sample. Whereas those infants with positive cultures were excluded from analysis, more than 20% of the infants studied were deemed clinically to have culturenegative sepsis based on clinical symptoms and/or raised inflammatory markers. Although sepsis may have been the cause, many of these infants may have had elevated inflammatory markers for noninfective reasons. 15 There has been recent controversy about the position of the COFN on the extended treatment of well infants born after chorioamnionitis, who have elevated inflammatory markers alone in the context of negative cultures. 7 A recent report indicates that continuation of antibiotics for prolonged courses is almost always a result of abnormal laboratory parameters and that only 16% of such infants have symptoms consistent with infection. 7 In our study, the introduction of a CRP measurement did not have a significant impact on this group of infants, and it is unlikely that improved diagnostic accuracy will be achieved until more sensitive investigations such as host response RNA or bacterial detection methods are validated in the clinical setting. 16 Pending the validation of such diagnostic techniques, it has been suggested that shorter treatment courses may be appropriate for some infants with EOS, with tailoring of ongoing treatment duration to inflammatory and other laboratory markers.
17,18
Conclusion
Use of an ASO and CRP measurement in infants with negative cultures curtails antibiotic duration and reduces the number of infants receiving avoidable doses. Use of CRP as an adjunct to clinical assessment did not lead to an increase in intervention. In the meantime, safe use of an ASO in neonatal prescriptions has the potential to significantly reduce exposure to both short-and longterm adverse effects of antibiotics, particularly in the most vulnerable infants.
